FDA Issues Letter to Industry on DSHEA Disclaimer - WholeFoods Magazine
FDA has issued a letter clarifying the requirements for DSHEA disclaimers in dietary supplement labeling; compliance is essential to avoid regulatory scrutiny.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All dietary supplement brands, contract manufacturers, and private-label sellers. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate review and implementation recommended.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Clarification on the requirements for DSHEA disclaimers in product labeling.
Who it affects
All dietary supplement brands, contract manufacturers, and private-label sellers.
What you must do
Review and update product labels to ensure compliance with DSHEA disclaimer requirements as outlined in the FDA letter.
Deadline
Immediate review and implementation recommended.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- August 10, 2026: Compounded peptide injections recalled due to high endotoxin levels - Partnership for Safe Medicines
- FDA: 12 Herbal Supplements Have Been Recalled - thehealthy.com
- FDA Educational Materials Outline New Dietary Ingredient Notification Process for Supplements - Quality Assurance & Food Safety
- IL HB0001: HEMP CANNABINOIDS-MINORS
- Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability